Functional OCT4-specific CD4(+) and CD8(+) T cells in healthy controls and ovarian cancer patients.
about
Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion.Monitoring cancer stem cells: insights into clinical oncology.Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.
P2860
Functional OCT4-specific CD4(+) and CD8(+) T cells in healthy controls and ovarian cancer patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Functional OCT4-specific CD4(+ ...... s and ovarian cancer patients.
@en
type
label
Functional OCT4-specific CD4(+ ...... s and ovarian cancer patients.
@en
prefLabel
Functional OCT4-specific CD4(+ ...... s and ovarian cancer patients.
@en
P2093
P2860
P356
P1433
P1476
Functional OCT4-specific CD4(+ ...... s and ovarian cancer patients.
@en
P2093
Leon F A G Massuger
Petra L M Zusterzeel
Tjitske Duiveman-de Boer
P2860
P304
P356
10.4161/ONCI.24271
P577
2013-04-01T00:00:00Z